uploads///RECOMMENDATIONS

Wall Street’s Recommendations for BSX Stock

By

Apr. 4 2018, Updated 2:10 p.m. ET

Analysts’ recommendations for Boston Scientific

Boston Scientific (BSX) has added a number of products to its portfolio through various strategic acquisitions, the latest being that of Securus Medical, discussed in the previous article of this series. Other recent acquisitions include that of NxThera and EMcision. In this article, we’ll discuss analysts’ recent recommendations and target prices for BSX stock.

As of April 4, 2018, of the 25 analysts covering Boston Scientific, 20 (80%) have recommended “buy” or “strong buy,” while five (20%) have recommended “hold.” There have been no “sell” recommendations.
Article continues below advertisement

Target price

As of April 4, 2018, analysts’ 12-month price target for BSX stock was $31.63, implying a return of ~15.2% based on the stock’s closing price of $27.46 on April 3, 2018.

On April 4, peers Abbott Laboratories (ABT), Edwards Lifesciences (EW), and Medtronic (MDT) had 12-month price targets of $68.33, $145, and $91.15, respectively, representing potential returns of 15.8%, 6.1%, and 16.3% over the next 12 months.

Wall Street recommendations and updates

On March 27, 2018, Needham reiterated its “buy” rating on BSX stock. It has a price target of $35 on the stock. On March 19, 2018, Morgan Stanley raised its 12-month price target on BSX stock from $30 to $33. In February 2018, Piper Jaffray initiated coverage on Boston Scientific with an “overweight” rating.

Advertisement

More From Market Realist

  • BioNano Genomics Saphyr system
    Company & Industry Overviews
    BioNano Genomics (BNGO) Stock Looks Like a Buy, Solid Opportunity
  • Delta aircraft
    Company & Industry Overviews
    Delta Air Lines Updates Mandatory Vaccine Policy, Explained
  • AMC advertisement in walkway
    Company & Industry Overviews
    Why It's Time for Most Investors to Sell AMC Entertainment Stock
  • 100 Thieves founder Matthew Haag
    Company & Industry Overviews
    Why Growing Esports Company 100 Thieves Isn't Publicly Traded
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.